On December 13, 2024, Ramiro Guerrero, a Director at MAIA Biotechnology Inc (MAIA, Financial), purchased 53,418 shares of the company. Following this transaction, the insider now owns a total of 514,970 shares. The transaction details are available in the SEC Filing.
MAIA Biotechnology Inc is a company focused on developing targeted immunotherapies for cancer treatment. The company aims to harness the body's immune system to combat cancer cells effectively.
The recent purchase by Ramiro Guerrero is part of a broader trend of insider buying at MAIA Biotechnology Inc. Over the past year, the insider has acquired a total of 148,880 shares and has not sold any shares. This aligns with the overall insider transaction history for the company, which shows 13 insider buys and no insider sells in the past year.
On the day of the recent purchase, shares of MAIA Biotechnology Inc were trading at $1.87, resulting in a market cap of $50.665 million. Investors may consider this insider activity as part of their evaluation of the company's stock, alongside other financial metrics such as the GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
